With a 10% tariff making Chinese products costlier, US importers may turn to Indian companies as cost-effective alternatives.

The stock market opened in the green on Thursday, February 13, 2025, as healthcare and pharmaceutical stocks rose. This comes ...

Stocks from manufacturing and outsourcing hubs stand to benefit under the China Plus One strategy; Technical chart shows that shares of Amber, Aurobindo and others can rally up to 33% from here on.

Bonus Mar 07, 2000 Apr 01, 2000 Feb 22, 2000 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Oct 26, 1998 Nov 19, 1998 Oct 08, 1998 Bonus Ratio: 1 share(s) for every 1 shares held Aurobindo ...

Report with market evolution powered by AI - The global antibiotics market size is estimated to grow by USD 18.22 billion ...

KR Choksey is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1591 in its ...

The global active pharmaceutical ingredients market size was worth USD 239.18 billion in 2024 and is expected to reach around USD 368.49 billion by 2033, with a noteworthy CAGR of 5.64% from 2023 to ...

Sri Aurobindo Institute of Pharmacy (SAIP), Indore, successfully hosted a National Conference on "Pharma Innovations: Cross-Disciplinary Approaches in Drug Development and Healthcare" on Friday, ...

Tata Steel is likely to raise around Rs 3,000 crore($345.6 million) through this bond issue and will likely complete the ...

The Nifty Pharma index closed on a positive note on Thursday. Shares of Ipca Laboratories Ltd.(up 5.01 per cent), J B ...

Aurobindo Pharma posted a mixed financial performance for the December quarter, with strong revenue growth but a decline in net profit and margins. The company’s earnings failed to meet analysts’ ...

IST, the barometer index, the S&P BSE Sensex, advanced 350.96 points or 0.46% to 76,519.26. The Nifty 50 index added 110.35 points or 0.48% to 23,155.60.